EUVIMEDEUVIMED entdecken
Crossref

Anti-Müllerian hormone as a potential marker of pubertal suppression in girls with central precocious puberty treated with GnRH agonists

Cemil Kocyigit iD, Tugce Candan Celik, Seda Erisen Karaca, Tugce Tiric Cevizbas, Sezer Acar

Journal of Pediatric Endocrinology and Metabolism · 19.11.2026

DOI: 10.1515/jpem-2026-0747 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, online erschienen am 19.11.2026. Verfasst von Cemil Kocyigit und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Endocrinology, University of Health Sciences, İzmir Tepecik Training and Research Hospital, İzmir, Türkiye. Die Arbeit nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare serum anti-Müllerian hormone (AMH) levels among girls with central precocious puberty (CPP) receiving gonadotropin-releasing hormone agonist (GnRH-a) treatment and prepubertal and pubertal controls, and to investigate the association between AMH levels and pubertal suppression.

Methods

This cross-sectional study included 50 GnRH-a–treated girls with CPP and 25 prepubertal and 25 pubertal controls. Pubertal suppression was assessed using three predefined criteria: reduced bone age advancement, stable/regressed breast Tanner stage, and annual height velocity ≤6 cm/year. Patients meeting 2–3 or 0–1 criteria were classified as having an adequate or inadequate pubertal suppression profile, respectively.

Results

AMH differed significantly among the groups (p=0.002) and was higher in CPP [2.93 (2.24–4.24) µg/L] than in pubertal controls [1.60 (1.05–2.72) µg/L; Bonferroni-adjusted p=0.003]. Among patients with CPP, 76 % had an adequate pubertal suppression profile. AMH was higher in patients with an adequate than an inadequate pubertal suppression profile [3.67 (2.53–4.70) vs. 2.56 (1.98–2.94) µg/L; p=0.028]. Suppression profiles also differed in anthropometric measures and GnRH-a exposure. Higher AMH was associated with stable/regressed breast Tanner stage (p=0.014) and height velocity ≤6 cm/year (p=0.034), but not reduced bone age advancement (p=0.763). AMH discriminated adequate and inadequate pubertal suppression profiles (AUC 0.714, 95 % CI 0.553–0.875; p=0.009); an exploratory threshold of ≥3.00 μg/L yielded 60.5 % sensitivity and 83.3 % specificity.

Conclusions

Serum AMH was higher in GnRH-a–treated girls with CPP than in pubertal controls and was associated with an adequate pubertal suppression profile. AMH may be a complementary biomarker for assessing pubertal suppression, although prospective validation is required.

Schlagwörter

Stichwörter der Autor:innen

GnRH agonistanti-Müllerian hormonecentral precocious pubertypubertal suppressiontreatment monitoring

Autor:innen und Institutionen

  • Division of Pediatric Endocrinology, University of Health Sciences, İzmir Tepecik Training and Research Hospital, İzmir, Türkiye.

ORCID-Profile: Cemil Kocyigit

Zitieren

APA

Kocyigit, C., Celik, T. C., Karaca, S. E., Cevizbas, T. T., & Acar, S. (2026). Anti-Müllerian hormone as a potential marker of pubertal suppression in girls with central precocious puberty treated with GnRH agonists. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2026-0747

Vancouver

Kocyigit C, Celik TC, Karaca SE, Cevizbas TT, Acar S. Anti-Müllerian hormone as a potential marker of pubertal suppression in girls with central precocious puberty treated with GnRH agonists. Journal of Pediatric Endocrinology and Metabolism. 2026. doi:10.1515/jpem-2026-0747

BibTeX
@article{Kocyigit2026,
  author = {Kocyigit, Cemil and Celik, Tugce Candan and Karaca, Seda Erisen and Cevizbas, Tugce Tiric and Acar, Sezer},
  title = {Anti-Müllerian hormone as a potential marker of pubertal suppression in girls with central precocious puberty treated with GnRH agonists},
  journal = {Journal of Pediatric Endocrinology and Metabolism},
  year = {2026},
  doi = {10.1515/jpem-2026-0747}
}
Kostenlos starten →